You’re almost registered.
Special Purpose Acquisition Corporations (SPACs) have grown in popularity, offering an alternative and efficient approach to funding innovation at scale. In this deep dive, Carol Coughlin will host guest expert Sandra Shpilberg, (founder, CEO & board director at Sanaby Health SPAC, the first SPAC founded by a Hispanic woman.) Together, they will explore the critical first steps a SPAC founder takes to enable the IPO. Learn how to assemble your internal team, board of directors, board of advisors, and external team, as well as how to maximize your chances of a successful IPO.
Carol is an experienced public company board leader, board and audit committee chair, and is highly skilled in corporate governance, including board refreshment, strategic alternatives and M&A for growth and highly regulated companies. She is a Board Leadership Fellow (NACD) and sits on the boards of the University of MD Medical Center and Trusty Care. Following an IPO and after nomination to board chair, she led the board through acquisitions that doubled the size of the company, followed by a merger with a larger company. A qualified “financial expert”, she is an accomplished healthcare CFO with a track record of achieving profitability through growth, highly successful turnarounds and M&A. She is known as an energetic, collaborative leader and a quick learner in both organizational and board settings. In 2006, Carol launched BottomLine Growth Strategies, Inc., a growth advisory firm helping CEOs of privately held companies to transform enterprise value through best practice financial and operations strategies. Carol is a graduate of Loyola University in MD (MBA) and Towson University (BS Business), is a Board Leadership Fellow (NACD), and a Certified Public Accountant.
Sandra Shpilberg is the founder and CEO of Seeker Health, a leading digital patient-finding platform and the author of New Startup Mindset. In 2015, Shpilberg founded Seeker Health to bring efficiency to the process of finding patients to accelerate the development of treatments for serious diseases. The company grew rapidly to serve sixty-plus biotechnology companies, connect millions of patients with serious diseases to clinical trials, and achieve profitability. In September 2018, a life science services conglomerate acquired her company. In her bestselling book, Shpilberg Shpilberg shares her story of starting, building, and exiting her digital health startup and provides readers with sage insights and practical tools to follow this approach. This book is simultaneously a needed dose of reality and a large serving of inspiration for those who want to create something from nothing – especially for those who think they might not fit the mold. Shpilberg now serves as angel investor and startup advisor, and is incubating her next company.
SPACs: A Deep Dive on Preparing the S-1 Filing for IPO
Wed, Sep 15 @ 9:00am PT (1 hr)
Virtual (RSVP for link)
To access this event, choose one of the options below.
Already a member? Log in here.
Not a member? Join an event or two on a trial basis. Contact us at [email protected].
Join a powerhouse community of executive women and gain support in every aspect of your senior leadership career.LEARN MORE